Board of directors

Stéphane Rousset, Chairman of the Board

Stéphane Rousset, Chairman of the Board 

Business Angel, mentor and advisor. Stéphane focuses on Swiss technology start-ups. His corporate career was in the Information and Communications Technology industry. He held C-level positions at Fujitsu and Oracle, after various leadership positions at Digital Equipment, AT&T, and Global One. Stéphane is an alumnus of EPFL, the University of California at Berkeley, and INSEAD.

Dr. Yves Dudal, Board Member and Lead Director

Dr. Yves Dudal, Board Member and Lead Director

Yves is a biotech engineer by training and received his PhD in chemical engineering. Yves has worked 8 years as academic researcher, leading to the foundation of his first start-up company in 2010, which was taken over by a European group in 2015. Yves was since the foundation the CEO of INOFEA until he moved to the CEO position of Perseo pharma. He continues supporting INOFEA as Lead Director.

Dr. Martin Riediker, Board Member

Dr. Martin Riediker, Board Member

Martin received his education in Chemistry and Business and General Management. He has more than 30 years’ experience in the chemical industry and is in the Board of various start-ups. Martin is a Member of the Commission for Education and Research of Economie-Suisse, and among other responsibilities also President Engineering Sciences of the Commission for Technology and Innovation

Dr. Werner Enz, Board Member

Dr. Werner Enz, Board Member

Werner holds a Doctorate in Medicine and an MBA. He is the Chief Executive Officer of EVA (in the meantime acquired by JFG Life Sciences Foundation of the University of Basel). He held various senior executive positions at Roche in Switzerland, Canada and Germany, Werner also worked for various innovative start-ups and mid-sized B2B technology companies in life science.